These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2242010)

  • 1. Hepatic subcellular localization of cresylbenzodioxaphosphorin oxide (CBDP)-sensitive soman binding sites.
    Little JS; Maxwell DM; Fox-Talbot MK; Brecht K; Lenz DE
    Biochem Pharmacol; 1990 Oct; 40(8):1733-7. PubMed ID: 2242010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of carboxylesterase inhibition on interspecies differences in soman toxicity.
    Maxwell DM; Brecht KM; O'Neill BL
    Toxicol Lett; 1987 Nov; 39(1):35-42. PubMed ID: 3672554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cresylbenzodioxaphosphorin oxide pretreatment alters soman-induced toxicity and inhibition of tissue cholinesterase activity of the rat.
    Jimmerson VR; Shih TM; Maxwell DM; Mailman RB
    Toxicol Lett; 1989 Jul; 48(1):93-103. PubMed ID: 2749782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of aliesterase as a detoxification mechanism for soman (Pinacolyl methylphosphonofluoridate) in mice.
    Clement JG
    Biochem Pharmacol; 1984 Dec; 33(23):3807-11. PubMed ID: 6508835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of aliesterase in organophosphate poisoning.
    Clement JG
    Fundam Appl Toxicol; 1984 Apr; 4(2 Pt 2):S96-105. PubMed ID: 6724216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of carboxylesterase inhibition on carbamate protection against soman toxicity.
    Maxwell DM; Brecht KM; Lenz DE; O'Neill BL
    J Pharmacol Exp Ther; 1988 Sep; 246(3):986-91. PubMed ID: 3418520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum carboxylesterase activity in various strains of rats: sensitivity to inhibition by CBDP (2-/o-cresyl/4H:1:3:2-benzodioxaphosphorin-2-oxide).
    Clement JG; Erhardt N
    Arch Toxicol; 1990; 64(5):414-6. PubMed ID: 2403290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pretreatment with CBDP on the toxicokinetics of soman stereoisomers in rats and guinea pigs.
    Due AH; Trap HC; Van Der Wiel HJ; Benschop HP
    Arch Toxicol; 1993; 67(10):706-11. PubMed ID: 8135661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of carboxylesterase in protection against soman toxicity.
    Purshottam T; Srivastava R
    Pharmacology; 1989; 38(5):319-26. PubMed ID: 2762374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcellular localization of non-specific carboxylesterases, acylcarnitine hydrolase, monoacylglycerol lipase and palmitoyl-CoA hydrolase in rat liver.
    Mentlein R; Rix-Matzen H; Heymann E
    Biochim Biophys Acta; 1988 Mar; 964(3):319-28. PubMed ID: 2894861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoisomers of soman (pinacolyl methylphosphonofluoridate): inhibition of serum carboxylic ester hydrolase and potentiation of their toxicity by CBDP (2-(2-methylphenoxy)-4H-1,3,2-benzodioxaphosphorin-2-oxide) in mice.
    Clement JG; Benschop HP; DeJong LP; Wolthuis OL
    Toxicol Appl Pharmacol; 1987 Jun; 89(1):141-3. PubMed ID: 3590185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of hepatic microsomal esterase activity following soman pretreatment in guinea pigs.
    Luttrell WE; Castle MC
    Biochem Pharmacol; 1993 Dec; 46(11):2083-92. PubMed ID: 8267657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of 2-/o-cresyl/-4 H-1 : 3 : 2-benzodioxa-phosphorin-2-oxide (CBDP) on organophosphate poisoning and its therapy.
    Bosković B
    Arch Toxicol; 1979 Jul; 42(3):207-16. PubMed ID: 475595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A purified recombinant organophosphorus acid anhydrase protects mice against soman.
    Broomfield CA
    Pharmacol Toxicol; 1992 Jan; 70(1):65-6. PubMed ID: 1317565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of CBDP and MEPQ on the toxicity and distribution of [3H]-soman in mice.
    Shapira S; Kadar T; Cohen G; Chapman S; Raveh L
    Arch Toxicol; 1990; 64(8):663-8. PubMed ID: 2090035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of tolerance to the organophosphorus anticholinesterase paraoxon with carboxylesterase inhibitors.
    Yang ZP; Dettbarn WD
    Biochem Pharmacol; 1998 May; 55(9):1419-26. PubMed ID: 10076534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of endogenous carboxylesterase on HI-6 protection against soman toxicity.
    Maxwell DM; Koplovitz I
    J Pharmacol Exp Ther; 1990 Aug; 254(2):440-4. PubMed ID: 2384881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of hepatic carboxylesterase activity by soman: inhibition in vitro and enhancement in vivo.
    Castle MC
    Xenobiotica; 1989 Jan; 19(1):115-21. PubMed ID: 2756715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereoselectivity of enzymes involved in toxicity and detoxification of soman.
    Nordgren I; Lundgren G; Puu G; Holmstedt B
    Arch Toxicol; 1984 Mar; 55(1):70-5. PubMed ID: 6732508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of three reputed carboxylesterase inhibitors upon rat serum esterase activity.
    Chambers JP; Hartgraves SL; Murphy MR; Wayner MJ; Kumar N; Valdes JJ
    Neurosci Biobehav Rev; 1991; 15(1):85-8. PubMed ID: 2052204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.